News

August 7, 2018August 7, 2018

Hospitalized COPD Patients with AFib More Likely to Develop Complications, Study Reports

News

Hospitalized patients with chronic obstructive pulmonary disease (COPD) who also suffer from atrial fibrillation (AFib), a condition where the heart beats faster, have a greater risk of developing liver ... Read more

August 3, 2018August 3, 2018

Verona Launches Phase 2 Trial Testing Investigational RPL554 Added to Stiolto Respimat

News

Verona Pharma has started a Phase 2 clinical trial to evaluate the potential of its nebulized RPL554 as an add-on treatment to the approved Stiolto Respimat (tiotropium bromide/olodaterol) for the ... Read more

July 31, 2018July 31, 2018

Inhaled Vaporized Cannabis Failed to Improve COPD Symptoms in Small Clinical Trial

News

Inhaling vaporized cannabis does not improve breathlessness or exercise endurance in patients with advanced chronic obstructive pulmonary disease (COPD), according to a small Canadian study. The study reporting the ... Read more

July 27, 2018July 27, 2018

FDA Advisory Committee Does Not Support Approval of GSK’s Mepolizumab for COPD

News

The U.S. Food & Drug Administration’s Pulmonary Allergy Drugs Advisory Committee voted that the risk-benefit profile of GSK’s mepolizumab was not adequate to support its approval as an add-on treatment ... Read more

July 24, 2018July 24, 2018

COPD Treatment with Targeted Lung Denervation Found Safe and Feasible, Study Reports

News

Treatment of chronic obstructive pulmonary disease (COPD) with a minimally invasive investigative procedure called targeted lung denervation (TLD) is feasible, safe, and was found to improve lung function, according ... Read more

July 17, 2018July 17, 2018

Low, Moderate Psychological Distress Increases Risk of COPD, Other Diseases, Study Shows

News

Psychological distress, even at low or moderate levels, increases the risk of arthritis, cardiovascular disease, and chronic obstructive pulmonary disease (COPD), researchers have found. This finding was reported in ... Read more

July 13, 2018July 13, 2018

Social Support, Regular Exercise Can Help COPD Patients Remain Active, Review Study Says

News

Consistent support from healthcare professionals, interaction with peers, and regular exercise can help people with chronic obstructive pulmonary disease (COPD) remain physically active over the long-term, a systematic review of ... Read more

July 10, 2018July 10, 2018

FDA Approves Zephyr Valve for Patients with Severe Emphysema

News

The U.S. Food and Drug Administration (FDA) has approved Pulmonx’s Zephyr Endobronchial Valve, a device designed to treat patients with severe emphysema who experience difficulty breathing. Emphysema is a ... Read more

June 29, 2018June 29, 2018

New UK Study Recruiting Participants for Evaluation of Early COPD Risk Factors

News

A new clinical trial being conducted in the United Kingdom is recruiting participants to study the early stages of chronic obstructive pulmonary disease (COPD), and identify people at risk ... Read more

June 26, 2018June 26, 2018

Synairgen’s Antiviral Therapy SNG001 Proven Safe for COPD Patients in Phase 2 Trial

News

Preliminary results from a Phase 2 trial show that Synairgen’s investigative therapy SNG001 is well-tolerated by patients with chronic obstructive pulmonary disease (COPD). The ongoing two-part Phase 2 trial, called ... Read more

Pin It on Pinterest